nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
|
Frank, Ellen |
|
2008 |
5 |
3 |
p. 253-261 |
artikel |
2 |
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
|
Frank, Ellen |
|
2008 |
5 |
3 |
p. 253-261 |
artikel |
3 |
Alternative methods to evaluate trial level surrogacy
|
Abrahantes, Josè Cortiñas |
|
2008 |
5 |
3 |
p. 194-208 |
artikel |
4 |
Alternative methods to evaluate trial level surrogacy
|
Abrahantes, Josè Cortiñas |
|
2008 |
5 |
3 |
p. 194-208 |
artikel |
5 |
Authors' response
|
Owzar, Kouros |
|
2008 |
5 |
3 |
p. 223-224 |
artikel |
6 |
Authors' response
|
Owzar, Kouros |
|
2008 |
5 |
3 |
p. 223-224 |
artikel |
7 |
Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe
|
Chingono, Alfred |
|
2008 |
5 |
3 |
p. 273-276 |
artikel |
8 |
Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe
|
Chingono, Alfred |
|
2008 |
5 |
3 |
p. 273-276 |
artikel |
9 |
Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
|
Xian Zhou, |
|
2008 |
5 |
3 |
p. 181-193 |
artikel |
10 |
Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
|
Xian Zhou, |
|
2008 |
5 |
3 |
p. 181-193 |
artikel |
11 |
Commentary on `Designing phase II studies in cancer with time-to-event endpoints'
|
Case, Doug |
|
2008 |
5 |
3 |
p. 222-223 |
artikel |
12 |
Commentary on `Designing phase II studies in cancer with time-to-event endpoints'
|
Case, Doug |
|
2008 |
5 |
3 |
p. 222-223 |
artikel |
13 |
Designing phase II studies in cancer with time-to-event endpoints
|
Owzar, Kouros |
|
2008 |
5 |
3 |
p. 209-221 |
artikel |
14 |
Designing phase II studies in cancer with time-to-event endpoints
|
Owzar, Kouros |
|
2008 |
5 |
3 |
p. 209-221 |
artikel |
15 |
Enhancing communication among data monitoring committees and institutional review boards
|
Taylor, Holly A |
|
2008 |
5 |
3 |
p. 277-282 |
artikel |
16 |
Enhancing communication among data monitoring committees and institutional review boards
|
Taylor, Holly A |
|
2008 |
5 |
3 |
p. 277-282 |
artikel |
17 |
Erratum
|
|
|
2008 |
5 |
3 |
p. 283-283 |
artikel |
18 |
Erratum
|
|
|
2008 |
5 |
3 |
p. 283 |
artikel |
19 |
Imputation methods for missing outcome data in meta-analysis of clinical trials
|
Higgins, Julian PT |
|
2008 |
5 |
3 |
p. 225-239 |
artikel |
20 |
Imputation methods for missing outcome data in meta-analysis of clinical trials
|
Higgins, Julian PT |
|
2008 |
5 |
3 |
p. 225-239 |
artikel |
21 |
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
|
Demark-Wahnefried, Wendy |
|
2008 |
5 |
3 |
p. 262-272 |
artikel |
22 |
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer
|
Demark-Wahnefried, Wendy |
|
2008 |
5 |
3 |
p. 262-272 |
artikel |
23 |
Reformulating the hazard ratio to enhance communication with clinical investigators
|
Moser, Barry K |
|
2008 |
5 |
3 |
p. 248-252 |
artikel |
24 |
Reformulating the hazard ratio to enhance communication with clinical investigators
|
Moser, Barry K |
|
2008 |
5 |
3 |
p. 248-252 |
artikel |
25 |
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements
|
Margolis, Karen L |
|
2008 |
5 |
3 |
p. 240-247 |
artikel |
26 |
Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements
|
Margolis, Karen L |
|
2008 |
5 |
3 |
p. 240-247 |
artikel |